ALGIERS, — Algeria’s pharmaceutical group SAIDAL will soon be exporting its products to 13 African countries, under an agreement signed with an exclusive distributor, says its General Manager, Mohamed Hamouche.

Preparations for the export operations “have begun in February following the signing of a partnership agreement between SAIDAL and a group in charge of distributing SAIDAL’s products in 13 African countries, namely Cote d’Ivoire, Gabon, Senegal, Cameroon, Mali, Congo, the Democratic Republic of Congo (DRC), Niger, Togo, Benin, Guinea-Bissau, Chad and Mauritania,” Hamouche told APS here Tuesday.

He added that this experience would open the way for the group to broaden the operation to exporting.

Cote d’Ivoire will be the first country to receive SAIDAL’s products after the visit of Ivorian experts to the group’s production facilities in Algiers, Medea and Constantine last week.

Hamouche said SAIDAL applied in an invitation for tenders in Cote d’Ivoire for the marketing of 50 drugs for use in that West African country’s hospitals.

He also underlined the need for the Algerian pharmaceutical industry to turn to exporting, as 70 per cent of domestic needs have been met and new production facilities are still about to come online.

He added that SAIDAL’s export operations were part of the new measures taken by the Algerian government to promote non-oil, gas exports.

Source: Name News Network

Related Post
SafeTraces also received a prestigious FDA SBIR Phase II grant to advance commercialization of its